VIGLIM M 2/850 GLIMEPIRIDE 2mg. IP + METFORMIN 850mg. IP

Viglim M 2/850 tablets combine glimepiride and metformin to improve blood sugar control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; used when diet, exercise and a single medicine are not enough to keep blood sugar in range; helps lower both fasting and after-meal blood sugar levels; helps improve glycemic control as part of a regular diabetes care plan.

Common side effects of Viglim M 2/850 Tablet include hypoglycemia (low blood sugar); headache; dizziness; nausea; weakness (asthenia); diarrhoea. Get medical help at once if you notice severe hypoglycemia; lactic acidosis (a build-up of lactic acid in the blood, linked to metformin); hemolytic anemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Each Viglim M 2/850 tablet contains Glimepiride 2 mg + Metformin 850 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim M 2/850 Tablet only as your doctor advises.

The MRP of Viglim M 2/850 Tablet is ₹139.69 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹106.43 and the PTS is ₹95.79.

Each Viglim M 2/850 tablet contains Glimepiride 2 mg + Metformin 850 mg. It comes in a pack of 10x15 (Blister).

The two ingredients work in different ways to lower blood sugar. Glimepiride acts on the pancreas to stimulate the release of insulin, so more insulin is available to take sugar out of the blood. Metformin belongs to the biguanide class and reduces the amount of sugar produced by the liver while helping the body use its own insulin. Together they improve glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus.

Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used in patients with severe renal impairment (eGFR below 30 mL/min/1.73 m2). Must not be used in patients with acute or chronic metabolic acidosis. Must not be used by patients with a known allergy to glimepiride, metformin or sulfonamide derivatives. Check with a doctor first if you have any kidney or liver problems (kidney function should be assessed and monitored during treatment), are elderly, drink alcohol heavily, are pregnant or breastfeeding, or use other diabetes medicines.

Viglim M 2/850 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.